Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

The effects of a new seat suspension system on whole body vibration exposure and driver low back pain and disability: results from a randomized controlled trial in truck drivers [with consumer summary]
Dennerlein JT, Cavallari JM, Kim JHJ, Green NH
Applied Ergonomics 2022 Jan;98:103588
clinical trial
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

Through a randomized controlled trial, we evaluated the effects of an electro-magnetic active seat suspension that reduces exposure of a long-haul truck driver to whole body vibration (WBV) on low back pain (LBP) and disability. Among 276 drivers recruited from six trucking terminals of a major US trucking company, 135 eligible drivers were assigned to either having an active seat (intervention, n = 70) -- the BoseRide electro-magnetic active seat -- or passive seat (reference, n = 65) -- a new version of their current seat (passive air suspension seat) -- installed in their truck via block (terminal) randomization. Low back pain (LBP) severity, on a 0 to 10 scale and the Oswestry LBP Disability Index were collected before and 3-, 6-, 12-, 18-, and 24-months post seat installation. LBP severity and LBP disability scores were significantly lower post seat installation in both groups. At 3 months, LBP severity decreased -1.4 (95% CI -2.1 to -0.7, n = 46) for drivers in the active seat arm, and -1.5 (95% CI -2.3 to -0.8, n = 41) for drivers in the passive seat arm. In a subset of drivers, WBV exposures were collected before and after the seat installation. WBV exposures significantly decreased post seat installation for active seat (p < 0.01) but not for passive seat (p = 0.15). While the new seat-suspension technology reduced WBV exposures, LBP appeared to be improved by multiple factors. These results were limited by the secondary prevention approach and the longer-term loss to follow up due to large rates of driver turnover typical for the industry.
With permission from Excerpta Medica Inc.

Full text (sometimes free) may be available at these link(s):      help